A.el-GabalawyH.de KievitT.et al
8.4 Pediatric Use Treatment of Influenza The safety and efficacy of TAMIFLU for the treatment of influenza in pediatric patients 2 weeks old to 17 years of age has been established [see Dosage and Administration (2.2), Clinical Pharmacology (12.3), and Clinical Studies (14.1)] and is based on: 13 to 17 years of age: Safety and efficacy in adolescent patients 13 to 17 years of age was supported by adequate and well-controlled trials in adults and adolescents and younger pediatric patients and safety data in adolescents treated with TAMIFLU in a study of treatment and prophylaxis
You can use RetaTracker to track food noise, hunger, cravings, protein, hydration, energy, sleep quality, mood, side effects, notes, wins, and weekly progress
Eating well on GLP-1 medications doesnt have to be expensive